Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Eyenovia Inc (NQ: EYEN ) 0.7854 +0.0254 (+3.34%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Eyenovia Inc < Previous 1 2 3 4 Next > NASDAQ:EYEN Investor Notice: Investigation over Potential Wrongdoing at Eyenovia, Inc. October 11, 2023 San Diego, CA -- (SBWIRE) -- 10/11/2023 -- Certain directors of Eyenovia, Inc. are under investigation over potential breaches of fiduciary duties. Via SBWire Porch Group And 2 Other Stocks Under $3 Insiders Are Buying September 20, 2023 The Dow Jones closed lower by over 100 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities Earnings Preview For Eyenovia August 09, 2023 Via Benzinga Glancy Prongay & Murray LLP Announces Investigation of Eyenovia, Inc. (EYEN) June 15, 2023 From Glancy Prongay & Murray LLP Via Business Wire Eyenovia Expands Its US Manufacturing Capabilities June 06, 2023 Via ACCESSWIRE Eyenovia, Inc. (NASDAQ:EYEN) Investor Notice: Investigation over Possible Securities Laws Violations May 24, 2023 San Diego, CA -- (SBWIRE) -- 05/24/2023 -- An investigation was announced for investors of Eyenovia, Inc. (NASDAQ:EYEN) shares over potential securities laws violations by Eyenovia, Inc. Via SBWire Recap: Eyenovia Q1 Earnings May 11, 2023 Via Benzinga A Preview Of Eyenovia's Earnings May 10, 2023 Via Benzinga Eyenovia Inc. (NASDAQ: EYEN) Records 52-Week High Tuesday Morning April 04, 2023 Via Investor Brand Network Preview: Eyenovia's Earnings March 29, 2023 Via Benzinga Eyenovia Shares Dip Despite FDA Approving Its First Product May 08, 2023 The FDA approved Eyenovia Inc's (NASDAQ: EYEN) Mydcombi (tropicamide and phenylephrine hydrochloride ophthalmic spray) 1%/2.5% for inducing mydriasis for diagnostic procedures and in conditions where... Via Benzinga Glancy Prongay & Murray LLP Announces Investigation of Eyenovia, Inc. (EYEN) May 08, 2023 From Glancy Prongay & Murray LLP Via Business Wire Top 5 Health Care Stocks That May Fall Off A Cliff This Quarter April 17, 2023 The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. Via Benzinga Eyenovia Showcases Microdose Array Print (MAP™) Technology at CES 2023 in Las Vegas January 31, 2023 In the Digital Health and Startups category at the 2023 Consumer Electronics Show (CES), Eyenovia showcased its Microdose Array Print (MAP™) Technology, the first significant advancement in ocular drug... Via Newswire.com Eyenovia's Optejet Shows Lower Proinflammatory Cytokines Levels, Chemokines Than Standard Drops January 12, 2023 Via Benzinga HC Wainwright Initiates This Eye-Focused Stock With Almost 400% Upside October 05, 2022 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session January 12, 2023 Via Benzinga Eyenovia Aims to Revolutionize Ophthalmology Devices With Microdose Array Print (MAP) Technology December 22, 2022 The Microdose Array Print (MAP) Technology has shown potential in clinical trials, providing the possibility of more accurate ocular drug delivery than traditional eye droppers Via Newswire.com Earnings Outlook For Eyenovia November 09, 2022 Eyenovia (NASDAQ:EYEN) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement. Analysts estimate that Eyenovia will... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session October 20, 2022 Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock increased by 45.5% to $1.76 during Thursday's pre-market session. The market value of their outstanding shares is at $96.2 million. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday October 17, 2022 Good morning, investor! It's time to start off the trading week with a breakdown of the biggest pre-market stock movers on Monday! Via InvestorPlace Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket October 17, 2022 Gainers Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2022 October 05, 2022 Upgrades Via Benzinga Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday September 09, 2022 Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session September 01, 2022 Via Benzinga Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday September 02, 2022 Gainers Via Benzinga Eyenovia's Novel Optejet® Dispenser Puts People's Eyes First August 30, 2022 While traditional eye drop bottles require hand-eye coordination and deliver four to five times more medication than the human eye can hold, the Optejet® dispenser's human-centric design administers an... Via Newswire.com Stocks That Hit 52-Week Lows On Thursday August 25, 2022 On Thursday, 63 companies set new 52-week lows. Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session August 24, 2022 Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) shares moved upwards by 20.1% to $1.79 during Wednesday's after-market session. The market value of their outstanding shares is at $31.6 million. Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session August 10, 2022 Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.